524748 — Link Pharmachem Income Statement
0.000.00%
Last trade - 00:00- IN₹168.30m
- IN₹225.48m
- IN₹254.33m
- 74
- 55
- 50
- 66
Annual income statement for Link Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 348 | 536 | 388 | 299 | 254 |
| Cost of Revenue | |||||
| Gross Profit | 170 | 171 | 174 | 132 | 129 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 325 | 510 | 370 | 316 | 262 |
| Operating Profit | 22.7 | 26.1 | 17.9 | -16.8 | -8.13 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 16.8 | 26.2 | 8.86 | -19.2 | -14 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 10.8 | 18.8 | 6.54 | -13.6 | -10.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 10.8 | 18.8 | 6.54 | -13.6 | -10.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 10.8 | 18.8 | 6.54 | -13.6 | -10.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.68 | 4.05 | 1.47 | -3.18 | -2.31 |